Small Cap Nation (SCN) interviews Dan McClory on Boustead's recent Reg A+ and IPO deals

Boustead Securities
Aug 18, 2017
1 min read

SCN Corporate Connect's Jane King sits down with Dan McClory, the Managing Director & Head of Equity of Boustead Securities, at the Nasdaq MarketSite to discuss Boustead's recent Reg A+ and IPO deals.

Recent Posts

See All

Boustead Securities Client Brera Holdings PLC (Nasdaq: BREA) Signs Exclusive Letter of Intent to Acquire Italian Serie B Football Club

Miami, New York and Milan, Italy – September 26, 2024 – Boustead Securities, LLC (“Boustead”) client Brera Holdings PLC (“Brera...

Boustead Client Reticulate Micro, Inc. to Collaborate on Satellite Video Compression Technology with Viasat

Irvine, CA – September 19, 2024 - Boustead client Reticulate Micro, Inc. ("Reticulate Micro"), a commercial and defense technology...

Boustead Announces Closing of NYSE IPO for Client Kairos Pharma (NYSE: KAPA) in its $6.2 Million Initial Public Offering

Irvine, CA — September 18, 2024 – Boustead Securities, LLC (“Boustead”) client Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”)...

Comments